Stay Informed and Engaged: Explore the Newest CME/CE Opportunities!

Advance your expertise and network with professionals in your field at our live events PRIME Trending CME/CE Update Monday November 13, 2023 View the latest CME/CE, curated specifically on topics that matter to you most. We've included popular updates and expert insights across specialties. Join your colleagues at our Live/Virtual Events or view an On-Demand Activity on your own time. UPCOMING LIVE EVENTS [Developing Advanced Strategies to Promote Health Equity in Multiple Sclerosis Care]( [1.0 CME/CE]( [Register Now]( [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [1.5 CME/CE]( [Register Now]( ON-DEMAND ACTIVITIES [Forging Pathways to Equity in IBD: Community Insights and Actionable Strategies]( [1.0 CME/CE]( [Access Now]( [Optimizing Patient-Centered Care in Pediatric Hereditary Angioedema in an Era of Novel Prophylactic Treatments]( [0.5 CME/CE]( [Access Now]( [Clinical Case Challenge: Recognizing and Managing Adverse Events Associated with Combination Therapies in a Patient with Advanced Melanoma]( [0.25 CME/CE]( [Access Now]( [Clinical Case Challenge: Treatment Decision-Making Based on Molecular Testing for a Patient with Advanced Melanoma]( [0.25 CME/CE]( [Access Now]( [Clinical Case Challenge: Evidence-based Treatment Sequencing for BRAF Wild-type Metastatic Melanoma]( [0.25 CME/CE]( [Access Now]( [Clinical Case Challenge: Recognizing and Managing Adverse Events Associated With Targeted Therapies Following First Line Immunotherapy in a Patient with Advanced Melanoma]( [0.25 CME/CE]( [Access Now]( [Prime Education] PRIME Education, LLC 114 5th Ave, 14th Floor New York, NY 10011 (954) 718-6055 | [Contact us]( PRIME is a multi-disciplinary accredited provider of continuing medical education. [Unsubscribe from future emails](lst=NL_Prime_Trending_CME) | [Contact us]( | [COVID-19 Resource Center](